These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8282334)

  • 1. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.
    Schiffrin EL; Deng LY; Larochelle P
    Hypertension; 1994 Jan; 23(1):83-91. PubMed ID: 8282334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension].
    Schiffrin EL; Deng LY; Larochelle P
    Arch Mal Coeur Vaiss; 1994 Aug; 87(8):979-81. PubMed ID: 7755476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
    Schiffrin EL; Deng LY; Larochelle P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S51-6. PubMed ID: 7700067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of remodeling and function of small arteries in human hypertension by cilazapril, an angiotensin I-converting enzyme inhibitor.
    Schiffrin EL
    J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S13-8. PubMed ID: 8723394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker.
    Schiffrin EL; Deng LY; Larochelle P
    Am J Hypertens; 1995 Mar; 8(3):229-36. PubMed ID: 7794571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients.
    Schiffrin EL; Deng LY
    Hypertension; 1995 Apr; 25(4 Pt 2):699-703. PubMed ID: 7721419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of resistance arteries in human hypertension: effects of cilazapril, an angiotensin-I-converting enzyme inhibitor.
    Schiffrin EL
    Cardiology; 1995; 86 Suppl 1():16-22. PubMed ID: 7614501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    Schiffrin EL
    Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.
    Schiffrin EL; Park JB; Intengan HD; Touyz RM
    Circulation; 2000 Apr; 101(14):1653-9. PubMed ID: 10758046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension.
    Thybo NK; Stephens N; Cooper A; Aalkjaer C; Heagerty AM; Mulvany MJ
    Hypertension; 1995 Apr; 25(4 Pt 1):474-81. PubMed ID: 7721386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.
    Schiffrin EL; Pu Q; Park JB
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):105-10. PubMed ID: 11863244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist.
    Schiffrin EL; Deng LY
    J Hypertens; 1996 Oct; 14(10):1247-55. PubMed ID: 8906525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic changes induced by cilazapril and atenolol during isometric stress in hypertensive patients.
    Pancera P; Arosio E; Priante F; Ribul M; De Marchi S; Lechi A
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):582-7. PubMed ID: 8314358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.
    Savoia C; Touyz RM; Amiri F; Schiffrin EL
    Hypertension; 2008 Feb; 51(2):432-9. PubMed ID: 18195160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension.
    Park JB; Intengan HD; Schiffrin EL
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):40-5. PubMed ID: 11967798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension.
    Savolainen A; Keto P; Poutanen VP; Hekali P; Standertskjöld-Nordenstam CG; Rames A; Kupari M
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):99-104. PubMed ID: 8656666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antihypertensive treatment on response to endothelin of resistance arteries of hypertensive rats.
    Deng LY; Schiffrin EL
    J Cardiovasc Pharmacol; 1993 May; 21(5):725-31. PubMed ID: 7685441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension.
    Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A
    Blood Press; 1995 Mar; 4(2):85-90. PubMed ID: 7599759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the sympathetic nervous system using heart rate variability and plasma hormones in hypertensive patients treated with cilazapril and atenolol.
    Campelo M; Polónia J; Serrão P; Cerqueira-Gomes M
    Cardiology; 1996; 87(5):402-8. PubMed ID: 8894261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.